He noted significant advancements in operational excellence, customer collaboration, and innovation, including the NovaSeq X transition and new partnerships. Illumina reported Q4 revenue of $1.1 ...

NovaSeq 6000 Sequencing System is designed to adapt to your needs so groundbreaking discoveries are always within reach. It's flexible, scalable science on your terms. NovaSeq 6000 offers deeper ...

Illumina's NovaSeq 6000 stands as the latest breakthrough in ultra-high throughput NGS sequencing instrumentation. This dual flow cell instrument is meticulously designed to function with four ...

In recent quarters, Illumina has focused on expanding its sequencing platforms and broadening application usages. Emphasis has been placed on customer adoption of its NovaSeq X platform ...

Further innovation, like the NovaSeq, continued to push down these ... genome when considering only the sequencing part of the process. Illumina also benefits from switching costs.

These solutions leverage the power of Illumina's leading NovaSeq X series platform and will enable researchers to derive breakthrough insights around the drivers of disease. The company will also ...

The combination of Illumina's Single Cell Prep, NovaSeq X Plus platform ... Together, these capabilities will help researchers process and analyze unprecedented volumes of single-cell reads with ...

Further innovation, like the NovaSeq, continued to push down ... when considering only the sequencing part of the process. Switching Costs Illumina also benefits from switching costs in its ...

Illumina is raising the curtain on its upcoming ... The company said its spatial technology will run on its current NextSeq and NovaSeq hardware through a new multimodal software platform, with ...

While Illumina had already preannounced its fourth-quarter results, TD Cowen highlighted that NGS consumable growth declined 3%, missing its 5% forecast, with weaker NovaSeq pull-through ...

Illumina has unveiled a new spatial technology that is designed to unlock further sequencing capabilities for researchers. Due for release in 2026, the US company’s technology for whole ...